首页> 外文期刊>Genetic Testing >Glyoxalase I and Aldose Reductase Gene Polymorphisms and Susceptibility to Carotid Atherosclerosis in Type 2 Diabetes
【24h】

Glyoxalase I and Aldose Reductase Gene Polymorphisms and Susceptibility to Carotid Atherosclerosis in Type 2 Diabetes

机译:乙二醛酶和醛糖还原酶基因多态性与2型糖尿病患者颈动脉粥样硬化的易感性

获取原文
获取原文并翻译 | 示例
       

摘要

Aims: To investigate the association of polymorphisms of glyoxalase I (GLO1) A419C, GLO1 C-7T, and aldose reductase C-106T with type 2 diabetes and diabetic carotid atherosclerosis in a Chinese Han population. Methods: The study population included 362 patients with type 2 diabetes and 301 nondiabetic control subjects. Genetic analyses were performed using either the Taqman polymerase chain reaction or direct sequencing. All patients with diabetes underwent carotid ultrasonography to assess the intima-media thickness and the presence of atherosclerotic plaques. Results: There were no differences between the genotype frequencies of GLO1 A419C, GLO1 C-7T, and aldose reductase C-106T polymorphisms, in the control and diabetic groups. The value of mean carotid intima-media thickness and the prevalence of carotid atherosclerotic plaques were significantly increased in patients with type 2 diabetes with the GLO1-7CC genotype compared with those with the -7CT and TT genotypes (permutation p = 0.003 and 0.031, respectively). Multiple regression analysis showed that the GLO1-7CC genotype was an independent determinant of carotid intima-media thickness (|3 = 0.12, p = 0.014), but not an independent risk factor for carotid atherosclerotic plaques (odds ratio [OR] =1.74, 95% CI 0.89-3.42, p - 0.10) in patients with type 2 diabetes. Conclusions: The GLO1 C-7T polymorphism is associated with carotid atherosclerosis in Chinese patients with type 2 diabetes.
机译:目的:探讨乙醛酶I(GLO1)A419C,GLO1 C-7T和醛糖还原酶C-106T多态性与中国汉族人群的2型糖尿病和糖尿病性颈动脉粥样硬化的关系。方法:研究人群包括362名2型糖尿病患者和301名非糖尿病对照受试者。使用Taqman聚合酶链反应或直接测序进行遗传分析。所有糖尿病患者均接受颈动脉超声检查,以评估内膜中层厚度和动脉粥样硬化斑块的存在。结果:在对照组和糖尿病组中,GLO1 A419C,GLO1 C-7T和醛糖还原酶C-106T多态性的基因型频率没有差异。与-7CT和TT基因型相比,GLO1-7CC基因型的2型糖尿病患者的平均颈动脉内中膜厚度值和颈动脉粥样硬化斑块的患病率显着增加(排列p分别为0.003和0.031) )。多元回归分析表明,GLO1-7CC基因型是颈动脉内膜中层厚度的独立决定因素(| 3 = 0.12,p = 0.014),但不是颈动脉粥样硬化斑块的独立危险因素(优势比[OR] = 1.74, 2型糖尿病患者的95%CI 0.89-3.42,p-0.10)。结论:GLO1 C-7T基因多态性与中国2型糖尿病患者的颈动脉粥样硬化有关。

著录项

  • 来源
    《Genetic Testing》 |2011年第4期|p.273-279|共7页
  • 作者单位

    Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated First People's Hospital 100 Haining Road Shanghai 200080 P.R. China;

    Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated First People's Hospital 100 Haining Road Shanghai 200080 P.R. China;

    Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated First People's Hospital 100 Haining Road Shanghai 200080 P.R. China;

    Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated First People's Hospital 100 Haining Road Shanghai 200080 P.R. China;

    Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated First People's Hospital 100 Haining Road Shanghai 200080 P.R. China;

    Department of Endocrinology and Metabolism Shanghai Jiao Tong University Affiliated First People's Hospital 100 Haining Road Shanghai 200080 P.R. China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:19:28

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号